UBC is helping to reshape health care through advances in genomics, proteomics, microbiomics and metabolomics, along with biomedical engineering and informatics. Our expanding ability to generate data from these realms, process it and act on it is transforming how we prevent, diagnose and manage complex diseases — moving away from a “one size fits all” strategy to approaches geared specifically to each individual patient.
Skip to Stories
Key Research Groups
- BC Cancer Agency Research Centre
- BC Children’s Hospital Research Institute
- British Columbia Genome Sciences Centre
- Djavad Mowafaghian Centre for Brain Health
- Edwin S.H. Leong Healthy Aging Program
- Life Sciences Institute
- Providence Health Care Research Institute
- Translational Cancer Genomics (TCG) cluster
- Vancouver Prostate Centre
- Women’s Health Research Institute
Spotlight
New DNA “clock” could help measure development in young children
This could allow for an earlier diagnosis of life-altering development disorders.
Read more >
UBC scientists capture images of gene-editing enzymes in action
Findings hold promise for future treatment of human diseases caused by DNA mutations.
Read more >
Scientists edge closer to root causes of multiple sclerosis
Researchers led by Carles Vilariño-Güell found mutations in 12 genes believed to be largely responsible for the onset of MS.
Read more >
A new way of diagnosing and treating disease — without cutting skin
UBC researchers develop new laser microscope that could be ‘revolutionary’ for treatment of diseases such as skin cancer.
Read more >
Global leader in precision cancer drug design joins the faculty of medicine
Dr. Sriram Subramaniam is recognized as a global leader in the emerging field of cryo-electron microscopy.
Read more >
Putting Canada at the forefront of precision medicine
Sriram Subramaniam joins UBC as the Gobind Khorana Canada Excellence Research Chair in Precision Cancer Drug Design.
Read more >
UBC attracts over $40M to host Networks of Centres of Excellence in nanomedicines
Led by Pieter Cullis, the NanoMedicines Innovation Network aims to develop nanomedicines that will deliver drugs more specifically to the sites of disease.
Read more >
New study first to identify an expanded section of DNA as cause of a rare genetic metabolic disorder
Researchers found an unusual genetic mutation behind three children’s undiagnosed, degenerative conditions.
Read more >
New tumour test could guide personalized treatment for children with cancer
Scientists at UBC and BC Children’s Hospital are the first in Canada to use a new test for pediatric tumour analysis.
Read more >
UBC researchers find gene signature that predicts outcome after spinal cord injury
The authors, including MD/PhD students, integrated data from decades of small-scale studies using a systems biology approach.
Read more >